Glycemic agents associated with phospholipids (PL) and cholesterol (Chol) as growth inhibitors of implanted tumours.
D000268:Adhesiveness; D000496:Alloxan / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects; D002784:Cholesterol / Q000494:pharmacology*; D004357:Drug Synergism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010743:Phospholipids / Q000494:pharmacology*; D051381:Rats; D012517:Sarcoma, Yoshida; D013501:Surface-Active Agents / Q000494:pharmacology
D000970:Antineoplastic Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D010743:Phospholipids; D013501:Surface-Active Agents; D000496:Alloxan; D002784:Cholesterol